AXQ Capital’s Strata Critical Medical Inc SRTA Stock Holding History

AXQ Capital’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,240	Closed	-$170K	–	1009
2025 Q4	$170K	Buy	+35,240	New	+$170K	0.04%	599

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $221M AUM

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AXQ Capital's SRTA Position: Q1 2026 in Review

AXQ Capital sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 35,240 shares — an estimated $170K sold.

AXQ Capital first reported a position in SRTA in Q4 2025 and held it in 1 quarter. The position peaked at $170K in Q4 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

AXQ Capital reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
AXQ Capital sold 35,240 Strata Critical Medical Inc shares in Q1 2026, an estimated $170K.
AXQ Capital first reported a position in Strata Critical Medical Inc in Q4 2025 and held it in 1 quarter.
AXQ Capital's Strata Critical Medical Inc position peaked at $170K in Q4 2025.
125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.